Dr. Jörg-Michael Scheil’s article titled „ Opportunities and legal restrictions in the Vietnamese healthcare market” available for download
Our partner, Dr. Jörg-Michael Scheil, authored an article titled “Chancen und rechtliche Beschränkungen im vietnamesischen Gesundheitsmarkt” (Opportunities and legal restrictions in the Vietnamese healthcare market), that was published by Insight Asia-Pacific (IAP), a magazine of the East Asian Association (OAV).
It is estimated that the total expenditures of the Vietnamese healthcare sector will reach USD 22.7 billion by 2021 with annual growth rate of 12.5%. This results in great opportunities for European manufacturers of medical devices, pharmaceuticals, food supplements and dietary foods. However, foreign producers have to deal with significant market access restrictions and to some extent confusing licensing requirements, that Dr. Scheil describes in his article.